Microbiology Seminar 🔬
Wednesday 4/8/26 12-1PM
CRB Austrian Auditorium
Matthias Schnell, PhD
"Immunogenicity of an adjuvanted, combination inactivated rabies-vectored, Lassa fever vaccine in healthy adults: Interim results of a first-in-human Phase 1 trial"